Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
de Boer RA, Doehner W, van der Horst IC, Anker SD, Babalis D, Roughton M, Coats AJ, Flather MD, van Veldhuisen DJ; SENIORS Investigators. de Boer RA, et al. Among authors: van der horst ic, van veldhuisen dj. Am J Cardiol. 2010 Jul 1;106(1):78-86.e1. doi: 10.1016/j.amjcard.2010.02.018. Am J Cardiol. 2010. PMID: 20609652 Clinical Trial.
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
de Boer RA, van Geel PP, Pinto YM, Suurmeijer AJ, Crijns HJ, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. Among authors: van gilst wh, van geel pp, van veldhuisen dj. J Cardiovasc Pharmacol. 2002 Apr;39(4):610-9. doi: 10.1097/00005344-200204000-00017. J Cardiovasc Pharmacol. 2002. PMID: 11904535
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
Shibata MC, Flather MD, Böhm M, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Parkhomenko A, Soler-Soler J, Tavazzi L, Toman J, Van Veldhuisen DJ, Coats AJ, Poole-Wilson P; Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure. Shibata MC, et al. Among authors: van veldhuisen dj. Int J Cardiol. 2002 Nov;86(1):77-85. doi: 10.1016/s0167-5273(02)00321-2. Int J Cardiol. 2002. PMID: 12243852 No abstract available.
Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction.
de Boer RA, Pinto YM, Suurmeijer AJ, Pokharel S, Scholtens E, Humler M, Saavedra JM, Boomsma F, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. Among authors: van gilst wh, van veldhuisen dj. Cardiovasc Res. 2003 Feb;57(2):434-42. doi: 10.1016/s0008-6363(02)00704-6. Cardiovasc Res. 2003. PMID: 12566116
Effect of lower body negative pressure in patients with mild congestive heart failure.
van den Berg MP, Tjeerdsma G, Lefrandt JD, Smit AJ, van den Meiracker AH, van Roon AM, Boomsma F, van Veldhuisen DJ. van den Berg MP, et al. Among authors: van den meiracker ah, van roon am, van veldhuisen dj. Am J Cardiol. 2003 Mar 15;91(6):759-62. doi: 10.1016/s0002-9149(02)03426-4. Am J Cardiol. 2003. PMID: 12633820 Clinical Trial. No abstract available.
Secondary prevention with folic acid: effects on clinical outcomes.
Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW, van Veldhuisen DJ. Liem A, et al. Among authors: van veldhuisen dj. J Am Coll Cardiol. 2003 Jun 18;41(12):2105-13. doi: 10.1016/s0735-1097(03)00485-6. J Am Coll Cardiol. 2003. PMID: 12821232 Free article. Clinical Trial.
1,179 results